Surface Catheter Securement Device Market - Global Forecast 2026-2032

The Surface Catheter Securement Device Market size was estimated at USD 205.50 million in 2025 and expected to reach USD 230.92 million in 2026, at a CAGR of 11.85% to reach USD 450.25 million by 2032.

Reliable catheter securement has emerged as a foundational component in modern patient care protocols, driven by a growing emphasis on minimizing complications and optimizing clinical workflows. As healthcare systems worldwide confront rising incidences of chronic conditions such as cardiovascular diseases, diabetes, and renal disorders, the reliance on long-term catheterization now exceeds historical norms. These trends have prompted hospitals, ambulatory centers, and home healthcare providers to seek advanced stabilization solutions designed to reduce infection rates, prevent accidental dislodgement, and streamline caregiving processes. Such devices are critical in safeguarding patient outcomes and reducing the broader economic burden posed by catheter-associated bloodstream infections (CRBSIs) and related complications.

Moreover, the expansion of outpatient procedures and telehealth services has reshaped clinical practice environments, driving demand for securement technologies that are not only clinically robust but also user-friendly for non-specialist caregivers. Innovations in adhesive formulations, integrated hub clamps, and absorbable sutures have enabled a new generation of catheter stabilization products to meet the dual imperatives of enhanced patient comfort and stringent infection control standards. As a result, the market has witnessed accelerated adoption of multi-component kits and evidence-based securement protocols that align with institutional quality benchmarks.

In the United States alone, approximately 410 million catheter stabilization devices were deployed across acute care, outpatient, and homecare settings in 2024, representing nearly 28% of the global volume and underscoring the critical role of securement technologies in complex care environments. With device manufacturers and healthcare leaders collaborating to refine best practices and regulatory frameworks, the surface catheter securement sector stands poised for continued innovation in patient safety and operational efficiency.

The catheter securement landscape has undergone transformative shifts in recent years as manufacturers and healthcare providers alike prioritize patient-centric design and infection prevention. Leading medical technology firms have introduced next-generation solutions featuring advanced adhesive substrates, antimicrobial dressings, and integrated anchoring mechanisms that deliver reliable stabilization in high-acuity environments. For example, 3M Health Care’s SecureEase+ Stabilization System combines antimicrobial protection with multidirectional anchoring to meet the exacting requirements of critical care units, supporting both central venous and peripherally inserted central catheters. Similarly, Smiths Medical has pioneered telehealth-enabled home-usage kits that equip non-clinical caregivers with easy-to-apply securement devices for urinary catheter management, reflecting a broader pivot toward decentralized care modalities.

In parallel, the industry’s shift toward non-invasive, needle-free securement methods has gained momentum, driven by regulatory emphasis on minimizing procedural trauma and reducing needlestick injuries among healthcare workers. Manufacturers such as TIDI Products have further expanded their portfolios through strategic acquisitions of eco-friendly startups, integrating sustainable materials into durable securement platforms that address environmental concerns without compromising clinical performance. Meanwhile, major players including ICU Medical and Merit Medical Systems continue to refine their pediatric-specific offerings, leveraging hypoallergenic adhesives and soft-tissue-friendly designs to ensure the safety and comfort of younger patient populations.

This wave of innovation is underpinned by emerging trends in material science-ranging from hydrocolloid dressings and transparent films to high-purity PVDF components-that facilitate longer wear times, improved skin integrity, and customizable adherence profiles. As healthcare delivery models evolve, these advanced solutions are reshaping clinical protocols and elevating the standard of care. The landscape’s ongoing transformation reflects a convergence of engineering ingenuity, regulatory imperatives, and patient-driven demands for safer, more effective catheter securement technologies.

The cumulative impact of the United States’ 2025 tariff landscape is reshaping the catheter securement device supply chain, imposing new cost pressures and operational complexities on manufacturers and healthcare providers. In February 2025, a 10% general tariff on Chinese imports was reinstated, while higher duties-reaching up to 34% on targeted source countries-were introduced under the so-called "Liberation Day" measures, which also applied a 10% levy on all U.S. imports effective April 5. These escalating tariffs have affected raw materials such as semiconductors used in advanced adhesive systems, as well as critical components like syringes, needles, and catheter anchors.

Industry data indicate that semiconductors, syringes, and needles will face tariff hikes up to 50%, while batteries, medical gloves, steel and aluminum parts, and other essential supplies will incur duties of 25% or higher. Given that medical supply expenditures constitute roughly 10.5% of an average hospital’s budget-totaling nearly $147 billion in 2023-health systems are bracing for significant inflationary pressures on consumables and securement accessories. Although multi-year contracts and buffer inventories have temporarily mitigated immediate price revisions, hospitals may ultimately pass cost increases through higher patient premiums or co-pays to preserve fiscal stability.

To abate tariff exposure, leading medtech players are accelerating U.S. manufacturing investments and supply chain realignments. In 2025, Boston Scientific indicated it would absorb a projected $200 million tariff impact while expanding production sites in Georgia and Minnesota, whereas Abbott committed similar investments in Illinois and Texas to bolster domestic capacity for transfusion and catheter-related devices. Conversely, smaller and mid-sized companies lacking comparable capital reserves are exploring alternative strategies, including partial cost pass-throughs to payers and selective curtailment of export volumes. As the tariff regime continues to evolve, the catheter securement market is navigating a complex interplay of protectionist policies, supply chain resilience mandates, and cost containment objectives.

A nuanced understanding of market segmentation is pivotal for stakeholders seeking to align product innovation and go-to-market strategies with evolving clinical and purchasing behaviors. Across the device type spectrum, the market encompasses Adhesive Securement Devices-characterized by foam-based, hydrocolloid, and transparent film variations-alongside Integrated Securement Devices, which leverage preconfigured catheter hubs or locking clamps, and Suture Securement Devices, differentiated by absorbable or non-absorbable suture materials. This diversity reflects the demand for tailored securement profiles, enabling clinicians to optimize stability while balancing patient comfort and device removal considerations.

When examining application categories, securement solutions are applied to arterial catheters-both femoral and radial-as well as to central venous catheters, which include non-tunneled and tunneled configurations, and to peripheral venous systems, with distinctions between long- and short-peripheral catheter placements. This tiered structure underscores the importance of context-specific securement approaches, as each anatomical site presents unique challenges related to mobility, dwell times, and infection risk.

End-user segmentation further highlights divergent purchasing practices, with ambulatory surgical centers (spanning general surgery and orthopedic applications), outpatient and specialty clinics, home healthcare providers, and both teaching and non-teaching hospitals exhibiting distinct volume drivers and protocol requirements. Distribution channels likewise range from direct sales agreements, often negotiated through group purchasing organizations or hospital contracts, to broad-scale networks of national and regional distributors, and burgeoning online platforms such as e-commerce marketplaces and manufacturer websites.

Finally, material preferences-encompassing polyurethane, silicone, and PVDF grades with varying purity specifications-play a critical role in performance characteristics, including adhesion strength, biocompatibility, and cost efficiencies. By synthesizing these multiple segmentation layers, market participants can pinpoint high-value niches and tailor product portfolios to address specialized clinical workflows and procurement models.

Geographic dynamics exert a defining influence on catheter securement device adoption, with marked differences in regulatory environments, healthcare infrastructure, and market maturity across the Americas, Europe Middle East & Africa (EMEA), and Asia-Pacific regions. In the Americas, North America retains a leadership position powered by extensive hospital networks, well-established infection control protocols, and a high volume of surgical and critical care interventions. The United States, in particular, leverages a robust supply chain ecosystem and substantial R&D investments to drive early adoption of advanced stabilization systems, reinforcing its status as the region’s primary growth engine.

In contrast, the EMEA region displays a balance of advanced Western European markets-characterized by aging populations and stringent regulatory requirements-and emerging markets across the Middle East and parts of Africa, where infrastructure expansion and rising healthcare expenditures are elevating demand for reliable securement solutions. Countries such as Germany and the United Kingdom lead in clinical standardization, while Gulf Cooperation Council states and South Africa are investing in capacity building to address rising procedural volumes.

Meanwhile, the Asia-Pacific region stands out as the fastest-growing market, fueled by burgeoning healthcare infrastructure developments in China, India, and Southeast Asia. Strategic expansions, such as B. Braun’s new production facility in Malaysia to localize device manufacturing, exemplify the sector’s response to regional supply chain optimization and cost-efficiency mandates. Additionally, government initiatives promoting domestic medical device production and reimbursement frameworks that support outpatient and homecare models are enabling greater market penetration of innovative securement devices.

Collectively, these regional distinctions underscore the need for differentiated market entry and expansion strategies, tailored regulatory compliance roadmaps, and localized partnerships that align with each region’s unique clinical practices and procurement channels.

The competitive landscape of the catheter securement device market is shaped by a blend of global medtech leaders and specialized niche innovators deploying diverse strategies to cement their market position. 3M Health Care has distinguished itself with the launch of its SecureEase+ Stabilization System, integrating antimicrobial dressings and multidirectional anchoring to address the complex demands of intensive care settings. BD (Becton, Dickinson and Company) has pursued a universal securement approach, introducing a versatile device compatible with arterial, venous, and urinary catheter formats, thereby streamlining procurement and training for healthcare systems.

Smiths Medical’s partnership with telehealth providers to distribute home-use securement kits underscores the company’s focus on expanding its reach into decentralized care models and improving patient self-management capabilities. B. Braun’s strategic investment in a Malaysia production hub exemplifies a localization strategy aimed at reducing lead times and tariff exposure in the Asia-Pacific, while Centurion Medical Products has captured a pediatric niche through the development of devices with enhanced skin adhesion and repositioning features.

TIDI Products has further broadened its sustainable product portfolio by acquiring an eco-friendly startup, positioning itself to meet growing demand for environmentally conscious clinical supplies. Additionally, ICU Medical and Merit Medical Systems continue to refine specialized securement solutions for vulnerable populations, with pediatric and dual-lock mechanisms respectively augmenting differentiation. Collectively, these firms illustrate a dynamic competitive environment wherein innovation, strategic manufacturing investments, and targeted partnerships define leadership trajectories.

To thrive amidst evolving clinical requirements and regulatory pressures, industry leaders should prioritize strategic investments in advanced adhesive technologies and integrated securement designs, ensuring product differentiation aligns with emerging care models. By focusing R&D efforts on high-value segments-such as hydrocolloid dressings with antimicrobial properties and high-purity PVDF components-manufacturers can cater to stringent infection control protocols while addressing patient comfort and skin integrity.

Adopting a diversified manufacturing footprint that balances domestic production with regional hubs will mitigate tariff exposure and supply chain disruptions. Strategic partnerships with group purchasing organizations and key hospital networks can streamline contract negotiations and foster early adoption through evidence-based pilot programs. In parallel, expanding direct engagement with home healthcare providers and telehealth platforms will capitalize on the growing decentralization of care, unlocking new revenue streams and reinforcing brand loyalty.

Moreover, companies should leverage data analytics and end-user insights to tailor training programs and digital resources that improve device application consistency and reduce clinical errors. Investing in sustainable materials and recyclable securement components will not only address environmental concerns but also appeal to procurement committees prioritizing corporate responsibility. Finally, forging alliances with regulatory bodies and accreditation agencies to co-develop securement guidelines will enhance market credibility, support reimbursement advocacy, and accelerate product deployment in both mature and emerging markets.

This market analysis integrates primary research insights and secondary data sources through a rigorous, multi-layered methodology designed to ensure reliability and relevance. Primary research comprised structured interviews with key opinion leaders, including clinical specialists, procurement directors, and distribution partners, who provided contextual perspectives on device adoption, procurement cycles, and end-user requirements.

Secondary research involved a thorough review of industry publications, peer-reviewed journals, regulatory filings, and public financial disclosures, enabling the consolidation of competitive intelligence and market trend validation. To quantify segmentation layers, a bottom-up approach was employed, triangulating shipment data, health system procurement records, and manufacturer revenue disclosures to establish credible demand estimates across device types, applications, and end-user categories.

Regional dynamics were assessed by analyzing government healthcare expenditure reports, import/export statistics, and tariff schedules, while company profiling drew on both global and regional annual reports, investor presentations, and patent filings. Expert consultations with supply chain analysts provided additional insights into logistics challenges, raw material sourcing, and manufacturing footprint strategies.

Finally, the synthesis of qualitative and quantitative findings was facilitated through scenario modeling and sensitivity analyses, ensuring that the conclusions reflect a robust understanding of market drivers, barriers, and future growth trajectories.

In summary, the surface catheter securement device market is positioned at the nexus of clinical innovation, cost management imperatives, and dynamic regulatory landscapes. The growing prevalence of chronic diseases and the decentralization of care delivery have elevated the importance of reliable stabilization solutions, propelling advancements in adhesive formulations, antimicrobial technologies, and integrated device designs. Concurrently, the imposition of 2025 U.S. tariffs has underscored the need for strategic supply chain realignment and nearshoring investments, compelling manufacturers to mitigate cost pressures while preserving global reach.

Comprehensive segmentation reveals that device type, application, end-user setting, distribution channel, and material composition collectively shape market opportunities, guiding product portfolio prioritization and go-to-market tactics. Regionally, North America leads in adoption due to mature healthcare ecosystems, while EMEA balances advanced markets and emerging economies, and Asia-Pacific delivers the fastest growth driven by infrastructure expansion and localization strategies.

Leading players are leveraging innovation pipelines, strategic manufacturing expansions, and targeted partnerships to differentiate their value propositions and address evolving clinical needs. By aligning R&D investments with high-purity materials, sustainable solutions, and homecare capabilities, industry participants can maintain competitive advantage. Ultimately, the integration of robust research insights, actionable recommendations, and adaptive strategies will empower organizations to navigate the complex intersection of patient safety, operational efficiency, and market growth.

To secure your competitive edge and gain deeper market clarity, engage today with Ketan Rohom, an experienced Associate Director of Sales & Marketing at 360iResearch who can guide you through tailored research solutions. Ketan brings extensive expertise in translating complex data into actionable insights specific to catheter securement technologies, ensuring that your organization leverages the latest intelligence to outpace competitors. Whether you seek customized deep-dive analysis, executive-level briefings, or strategic advisory support, Ketan can facilitate access to the full market research report, enabling rapid deployment of findings across your decision-making teams.

Contact Ketan to schedule a personalized consultation, learn about flexible licensing options, and explore value-added services including bespoke data modeling, scenario planning, and targeted end-user surveys. By partnering with Ketan, you will benefit from a consultative approach that aligns research deliverables to your strategic objectives, driving confidence in investment decisions and accelerating time to market. Discover how the definitive catheter securement device market research report can power your next growth initiative and empower your organization with the foresight needed to navigate evolving regulatory, technological, and competitive landscapes.

Connect with Ketan Rohom today and take the first step toward transforming insights into action, propelling your organization toward sustained success in the rapidly advancing catheter securement device market.